Caris Life Sciences

Pioneer in precision medicine.

Irving, Texas, United States

Precision Medicine/Diagnostics AI / MLPublic

Precision oncology platform with IPO in 2025

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Caris Life Sciences on @MedStartr Today Precision oncology platform with IPO in 2025. #CancerDiagnosis #CancerMonitoring #CancerTherapySelection #Cardiology #Neurology #MetabolicConditions #HematologicMalignancies #ChronicDiseases #CancerDetectionBreastLungCervical #CancerOncology #PrecisionMedicineDiagnostics #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/C26kspcB0ko

Get Involved in Caris Life Sciences

How We Help

Problem Statement

Caris Life Sciences addresses the challenge of providing individualized patient diagnoses and treatment by moving healthcare from intuitive to empirical medicine, utilizing precise molecular insights to improve patient outcomes.

Core Technology

Comprehensive molecular profiling, including Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) of both tissue and blood samples, advanced Artificial Intelligence (AI) and machine learning algorithms (e.g., Caris CODEai, Caris GPSai), proprietary aptamer-based proteomic profiling platforms (ADAPT), and whole slide imaging.

Key Differentiators

Comprehensive Molecular Profiling; Massive Clinico-Genomic Database; Advanced AI and Machine Learning; Focus on Precision Medicine; Innovative Solutions; Patient-Centric Approach; Strategic Partnerships.

Clinical Focus

Precision medicine, primarily in oncology (cancer detection, diagnosis, monitoring, and therapy selection), expanding to cardiology, neurology, metabolic conditions, hematologic malignancies, and other chronic diseases.

Target Customers

Physicians, Patients, Pharmaceutical companies, Research organizations, Biopharma companies.

Product Stage

GA/Mature

Company Info

Business Model: B2B, Services, Partnerships, Licensing. The company provides comprehensive molecular profiling services, R&D services for biopharma companies, and generates revenue through collaborations and licensing agreements with pharmaceutical companies and research organizations.
Founded: 2004
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.carislifesciences.com/

Disease Areas

Cancer Diagnosis Cancer Monitoring Cancer Therapy Selection Cardiology Neurology Metabolic Conditions Hematologic Malignancies Chronic Diseases Cancer Detection (Breast, Lung, Cervical)Cancer & Oncology

Technologies

Whole Exome SequencingMachine LearningMolecular ProfilingWhole Transcriptome Sequencing (WTS)Aptamer-Based ProfilingWhole Slide ImagingProteomicsAI & Machine Learning

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Caris Life Sciences?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.